What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 2: Clinic–Pathologic Correlations

What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 2: Clinic–Pathologic Correlations

Many studies have investigated the potential prognostic and predictive role of PD-L1 in prostatic carcinoma (PC). We performed a systematic literature review (PRISMA guidelines) to critically evaluate human tissue-based studies (immunohistochemistry, molecular analysis, etc.), experimental research...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Andrea Palicelli, Martina Bonacini, Stefania Croci, Cristina Magi-Galluzzi, Sofia Cañete-Portillo, Alcides Chaux, Alessandra Bisagni, Eleonora Zanetti, Dario De Biase, Beatrice Melli, Francesca Sanguedolce, Magda Zanelli, Maria Paola Bonasoni, Loredana De Marco, Alessandra Soriano, Stefano Ascani, Maurizio Zizzo, Carolina Castro Ruiz, Antonio De Leo, Guido Giordano, Matteo Landriscina, Giuseppe Carrieri, Luigi Cormio, Daniel M. Berney, Jatin Gandhi, Giacomo Santandrea, Maria Carolina Gelli, Alessandro Tafuni, Moira Ragazzi
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
PD-L1
prostate
cancer
adenocarcinoma
immunohistochemistry
target-therapy
Biology (General)
QH301-705.5
Accès en ligne:https://doaj.org/article/49bdba14c7fc4b88b941d1f188ef305f
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
Soyez le premier à ajouter un commentaire!
Il faut se connecter d'abord

Documents similaires